BFRI Stock Analysis: Buy, Sell, or Hold?
BFRI - Biofrontera Inc. Common Stock
$1.17
-0.06 (-4.88%)
▼
5d:
+7.34%
30d:
+15.84%
90d:
+8.33%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 12, 2026
9d
Get Alerted When BFRI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BFRI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BFRI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.24
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.39
16.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BFRI is currently trading at $1.17, which is considered extended relative to its 30-day fair value range of $1.01 to $1.15. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.7) compared to its historical average (5.0). Remarkably, the market is currently pricing in an annual earnings decline of 10.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BFRI is in a strong uptrend. Immediate support is located at $0.99, while resistance sits at $1.27. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: BFRI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.88 (+402.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BFRI is in a strong uptrend. Immediate support is located at $0.99, while resistance sits at $1.27. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: BFRI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.88 (+402.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.01 -
$1.15
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 402.1% below Wall St target ($5.88)
Trading Range Analysis
30-Day Trading Range
$1.01 -
$1.15
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.00
Resistance Level
$1.27
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.66
Wall Street Target
$5.88
(+402.1%)
Revenue Growth (YoY)
17.4%
Profit Margin
-25.7%
Valuation Discount vs History
-10.2% cheaper
PE vs Historical
3.7 vs 5.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.2%
(market-implied from PE analysis)
1-Year Target
$1.05
(-10%)
2-Year Target
$0.95
(-19%)
3-Year Target
$0.85
(-27%)
3-Yr Target (if PE normalizes)
(PE: 4→5)
$1.17
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.7 to 5.0
Stabilization Target:
$1.60
(+36.8%)
PE Expansion Potential:
+36.8%
Share & Embed Analysis
Last updated: August 02, 2026 4:35 PM ET
Data refreshes hourly during market hours. Next update: 5:35 PM
Data refreshes hourly during market hours. Next update: 5:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BFRI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 52 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 45 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
